Additionally, we divided the expression of linear CCDC7 into two groups according to the FPKM value in TCGA, and found that linear CCDC7 had no statistically significant association with prostate cancer patient survival (Supplementary Fig. 3h). This evidence concerns the gene CCDC7 and prostate carcinoma.